1Whiting D R,Guariguata L,Weil C,et al.IDF diabetes atlas:global estimates of the prevalence of diabetes for 2011and 2030[J].Diabetes Res Clin Pract,2011,94(3):311. 被引量：1
2Kahn S E,Cooper M E,Del Prato S.Pathophysiology and treatment of type 2 diabetes:perspectives on the past,present,and future[J].The Lancet,2014,383(9922):1068. 被引量：1
3Buse J B,Bergenstal R M,Glass L C,et al.Use of twicedaily exenatide in basal insulin-treated patients with type 2diabetes:a randomized,controlled trial[J].Ann Intern Med,2011,154(2):103. 被引量：1
4American Diabetes Association.Standards of medical care in diabetes-2010[J].Diabetes care,2010,33(S1):S11. 被引量：1
6Koshiba K,Nomura M,Nakaya Y,et al.Efficacy of glimepiride on insulin resistance,adipocytokines,and atherosclerosis[J].J Med Invest,2006,53(1/2):87. 被引量：1
7Seino S,Shibasaki T,Minami K.Dynamics of insulin secretion and the clinical implications for obesity and diabetes[J].J Clin Invest,2011,121(6):2118. 被引量：1
8Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes [ J ]. Diabetes, 2002, 51 (6): 1889-1895. 被引量：1
9Sattar N, Scherbakova O, Ford I, et al. Elevated alanine aminotransferase predicts new - onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C - reactive protein in the west of Scotland coronary prevention study [ J ]. Diabetes, 2004, 53 (11): 2855-2860. 被引量：1
10Gupte P, Amarapurkar D, Agal S, et al. Non - alcoholic steatohepatitis in type 2 diabetes rnellitus [ J ]. J Gastroenteml Hepatol, 2004, 19:854 -858. 被引量：1
